慢性膝关节假体周围感染重复二期翻修术后失败率高:一项多中心研究
这项多中心回顾性研究评估了48例慢性膝关节假体周围感染患者接受重复二期翻修术后的结局,平均随访12.1年。治疗成功率为39.6%,5年和10年全因翻修假体生存率分别为63.2%和42.3%,22.9%的患者需要截肢。年轻年龄是唯一独立失败预测因素(OR 0.898/年;95%CI 0.836-0.965;P=0.003)。
要点
- 重复二期翻修治疗慢性膝关节PJI的治疗成功率为39.6%(21/48)。
- 5年和10年全因翻修假体生存率分别为63.2%和42.3%,PJI特异性翻修生存率分别为65.1%和47.7%。
- 22.9%(11例)患者需要截肢,年轻年龄是唯一独立失败预测因素(OR 0.898/年;95%CI 0.836-0.965;P=0.003)。
核心结论
- 重复二期翻修治疗复发性膝关节PJI的感染控制率低,并发症发生率高,包括23%的截肢率。
- 年轻患者失败风险更高,这些发现强调需要仔细选择患者并探索替代策略。
研究设计与样本
- 多中心回顾性研究,回顾了两个三级中心前瞻性维护的数据库,纳入1995年至2022年间治疗的61例患者,其中13例(21.3%)未行再植入,最终48例(31%女性)纳入分析,平均随访12.1年。
主要发现
- 48例中21例(39.6%)达到治疗成功;27例失败中,21例接受进一步感染手术,2例持续终身抑制性抗生素治疗,4例接受无菌性翻修。
- 11例(22.9%)需要截肢。
- 全因翻修5年和10年假体生存率分别为63.2%和42.3%;PJI特异性翻修5年和10年生存率分别为65.1%和47.7%。
- 年轻年龄是唯一独立失败预测因素(OR 0.898/年;95%CI 0.836-0.965;P=0.003)。
- 排除培养阴性病例后,31%在重复翻修时出现新的感染微生物,多微生物感染增加(12.5%)。
关键数值与推荐
- 主要结局为根据2019年肌肉骨骼感染学会(Musculoskeletal Infection Society)1级标准判定的治疗成功。
- 采用Kaplan-Meier分析估计假体生存率,Cox回归识别失败预测因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recurrent periprosthetic joint infection (PJI) after two-stage revision total knee arthroplasty remains challenging. Repeat two-stage revision is a salvage option, but outcomes are poorly defined. This multicenter study evaluated the success of repeat two-stage knee revision for chronic PJI. METHODS: A retrospective review of prospectively maintained databases at two tertiary centers identified 61 patients treated between 1995 and 2022. There were 13 (21.3%) who did not undergo reimplantation, leaving 48 patients (31% women) who had a mean follow-up of 12.1 years. The primary outcome was treatment success per 2019 Musculoskeletal Infection Society tier 1 criteria. Kaplan-Meier analysis estimated implant survivorship; Cox regression identified predictors of failure. RESULTS: Treatment success was achieved in 21 of 48 cases (39.6%). Among 27 failures, 21 underwent further infection surgery, two remained on lifelong suppressive antibiotics, and four had aseptic revision. Amputation was required in 11 patients (22.9%). The five- and 10-year implant survival for all-cause revision was 63.2 and 42.3%, respectively; for PJI-specific revision, they were 65.1 and 47.7%, respectively. Younger age was the only independent predictor of failure (odds ratio 0.898 per year; 95% confidence interval 0.836 to 0.965; P = 0.003). Excluding culture-negative cases, 31% had a new infecting organism at repeat revision, and polymicrobial infection increased (12.5%). CONCLUSIONS: Repeat two-stage revision for recurrent knee PJI yields low infection control rates and major morbidity, including a 23% amputation rate. Younger patients are at greater risk of failure. These findings underscore the need for careful patient selection and exploration of alternative strategies.
引用
- Kennedy IW, Howard LC, Somerville L, et al. High Failure Rates Following Repeat Two-Stage Revision for Chronic Knee Periprosthetic Joint Infection: A Multicenter Study. J Arthroplasty. 2026. PMID: 41581711. doi:10.1016/j.arth.2026.01.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。